WO2005017104A3 - Cancer-linked gene as target for chemotherapy - Google Patents
Cancer-linked gene as target for chemotherapy Download PDFInfo
- Publication number
- WO2005017104A3 WO2005017104A3 PCT/US2004/018738 US2004018738W WO2005017104A3 WO 2005017104 A3 WO2005017104 A3 WO 2005017104A3 US 2004018738 W US2004018738 W US 2004018738W WO 2005017104 A3 WO2005017104 A3 WO 2005017104A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cancer
- methods
- target
- disclosed
- chemotherapy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47889403P | 2003-06-16 | 2003-06-16 | |
US60/478,894 | 2003-06-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005017104A2 WO2005017104A2 (en) | 2005-02-24 |
WO2005017104A3 true WO2005017104A3 (en) | 2006-07-06 |
Family
ID=34193027
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/018738 WO2005017104A2 (en) | 2003-06-16 | 2004-06-10 | Cancer-linked gene as target for chemotherapy |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2005017104A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2177630A1 (en) * | 2008-10-02 | 2010-04-21 | Institut Gustave Roussy | Methods for predicting or monitoring whether a patient affected by a cancer is responsive to a treatment with a molecule of the taxoid family |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001060860A2 (en) * | 2000-02-17 | 2001-08-23 | Millennium Predictive Medicine, Inc. | Genes differentially expressed in human prostate cancer and their use |
-
2004
- 2004-06-10 WO PCT/US2004/018738 patent/WO2005017104A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001060860A2 (en) * | 2000-02-17 | 2001-08-23 | Millennium Predictive Medicine, Inc. | Genes differentially expressed in human prostate cancer and their use |
Non-Patent Citations (2)
Title |
---|
DATABASE GENBANK [online] 15 July 2002 (2002-07-15), NISHI ET AL., Database accession no. (AK096745) * |
WEIGLE ET AL.: "D-PCA-2: A novel transcript highly overexpressed in Human prostate and prostate cancer", INT. J. CANCER, vol. 109, 2004, pages 882 - 892 * |
Also Published As
Publication number | Publication date |
---|---|
WO2005017104A2 (en) | 2005-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003097803A3 (en) | Cancer-linked gene as target for chemotherapy | |
WO2003101400A3 (en) | Cancer-linked gene as target for chemotherapy | |
WO2003105758A3 (en) | Cancer-linked gene as target for chemotherapy | |
WO2003104399A3 (en) | Cancer-linked gene as target for chemotherapy | |
WO2008020596A3 (en) | Treating or preventing cancers over-expressing reg4 or kiaa0101 | |
WO2005047458A3 (en) | Modified recombinant vaccina viruses and other microorganisms, uses thereof | |
WO2007113648A3 (en) | Ctla4 antibody combination therapy | |
WO2003072125A8 (en) | Therapeutic and diagnostic targeting of cancers cells with tumor homing peptides | |
WO2005005601A3 (en) | Compositions and methods for treating and diagnosing cancer | |
MX2009013646A (en) | Methods of diagnosing and treating cancer. | |
AU9016998A (en) | Methods and compositions for overcoming resistance to biologic and chemotherapy | |
WO2004031231A3 (en) | Genes and polypeptides relating to prostate cancers | |
WO2005120588A3 (en) | Peptides delivered to cell nuclei | |
WO2003066663A3 (en) | Peptides for recognition and targeting of glial cell tumors | |
WO2004037198A3 (en) | Antibody-mediated induction of tumor cell death | |
WO2005079490A3 (en) | Methods of therapy and diagnosis using targeting of cells that express steap2 polypeptides | |
WO2003076579A3 (en) | Cancer-linked gene as target for chemotherapy | |
WO2004026238A8 (en) | Immunotherapeutic compositions and methods for the treatment of moderately to well-differentiated cancers | |
WO2003104401A3 (en) | Cancer-linked gene as target for chemotherapy | |
WO2003104438A3 (en) | Cancer-linked gene as target for chemotherapy | |
WO2003097802A3 (en) | Cancer-linked gene as target for chemotherapy | |
WO2002031198A3 (en) | Cancer-linked genes as targets for chemotherapy | |
WO2005062788A3 (en) | Prostate specific proteins expressed in cancer and methods of use thereof | |
WO2005019475A3 (en) | Hypoxia-inducible protein 2 (hig2), a novel therapeutic potential target of renal cell carcinoma (rcc) | |
WO2003076587A3 (en) | Cancer-linked gene as target for chemotherapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
122 | Ep: pct application non-entry in european phase |